Infectious Disease Doctors in Brockton, MA Accepting Medicare

3 Infectious Disease doctors found. Showing 1 - 3

Nongnooch Poowanawittayakom, MD Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 63 Main Street, Brockton, MA 02301 Phone: 508-559-6699    Fax: 508-559-5073

Irma A Alarcon Najera, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 830 Oak St, Suite 105w, Brockton, MA 02301 Phone: 508-897-4794    Fax: 508-897-4781

Dr. Howard Kesselman, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 235 N Pearl St, Good Sam - Icu, Brockton, MA 02301 Phone: 508-427-3000

News Archive

Genetically targeted drugs used for lung cancer may also have applications in colorectal cancer patients

A University of Colorado Cancer Center study published online ahead of print in the journal Molecular Cancer Research shows that ALK and ROS1 gene rearrangements known to drive subsets of lung cancer are also present in some colorectal cancers. These results imply that drugs used to target ALK and ROS1 in lung cancer may also have applications in this subset of colorectal cancer patients.

A lead compound can significantly reduce or eliminate toxoplasmosis and malaria

Toxoplasma gondii infection is one of the most frequent parasitic infections of humans. This parasite is present in the brain of an estimated two billion people-about 40 percent of all humans on earth. It is endemic throughout the world, causing water and food-borne epidemics that result in toxoplasmosis.

New urine test could potentially reduce fatigue-related mistakes

Doctors, pilots, air traffic controllers and bus drivers have at least one thing in common — if they're exhausted at work, they could be putting lives at risk. But the development of a new urine test, reported in the ACS journal Analytical Chemistry, could help monitor just how weary they are.

Global AIDS epidemic continues to grow

The global AIDS epidemic continues to grow and there is concerning evidence that some countries are seeing a resurgence in new HIV infection rates which were previously stable or declining. However, declines in infection rates are also being observed in some countries, as well as positive trends in young people's sexual behaviours.

Perrigo receives final FDA approval for diclofenac sodium topical solution 1.5% w/w

Perrigo Company plc today announced that it has received final approval from the U.S. Food and Drug Administration on its Abbreviated New Drug Application (ANDA) for diclofenac sodium topical solution 1.5% w/w. Shipments to our pharmacy customers have commenced.

Read more Medical News

› Verified 9 days ago